Breadcrumb Home investors investor resources Investor Resources Quick Explore Corporate Governance Shareholding Pattern Investor contact Year 2026-20272025-20262024-20252023-20242022-20232021-20222020-20212019-20202018-20192017-2018 Apply Schedule of Analyst Institutional Investor Meetings 23rd Jun 2021 Allotment of 1,03,359 equity shares under ESOS 2013-A 16th Jun 2021 Press release - Avenue Therapeutics Receives Complete Response Letter from the FDA for IV Tramadol 15th Jun 2021 Schedule of Analyst Institutional Investor Meetings 11th Jun 2021 Schedule of Analyst Institutional Investor Meetings 07th Jun 2021 Response to Media Query 01st Jun 2021 Annual Secretarial Compliance Report 01st Jun 2021 Schedule of Analyst Institutional Investor Meetings 31st May 2021 Schedule of Analyst Institutional Investor Meetings 26th May 2021 Roche’s Antibody Cocktail (Casirivimab and Imdevimab) is now available in India, Cipla to market it pan-India 24th May 2021 + BSE and NSE Quotes by TradingView The displayed data is not in real time and may have streaming delays.